145 related articles for article (PubMed ID: 10632327)
1. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.
Koukourakis MI; Flordellis CS; Giatromanolaki A; Koukouraki S; Kapsoritakis A; Potamianos S; Retalis G; Sivridis E; Salsaa B; Harris AL; Maragoudakis MI
Clin Cancer Res; 1999 Dec; 5(12):3970-6. PubMed ID: 10632327
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of oral recombinant human granulocyte macrophage-colony stimulating factor in radiotherapy-induced esophagitis.
Koc M; Onuk MD; Koruk M; Memik F
Hepatogastroenterology; 2003; 50(53):1297-300. PubMed ID: 14571722
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
Madero L; Díaz MA; Ortega JJ; Olive T; Martínez A; Badell I; Muñoz A; Gómez P
Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
[TBL] [Abstract][Full Text] [Related]
4. [Granulocyte-macrophage colony-stimulating factor (GM-CSF), preclinical and phase I clinical investigations].
Shen B; Yang Z; Xu J
Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):654-7. PubMed ID: 9275545
[TBL] [Abstract][Full Text] [Related]
5. Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer.
Wagner W; Alfrink M; Haus U; Matt J
Anticancer Res; 1999; 19(1B):799-803. PubMed ID: 10216495
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells.
Du Z; Li Y; Xia H; Irani AM; Schwartz LB
J Immunol; 1997 Jul; 159(2):838-45. PubMed ID: 9218602
[TBL] [Abstract][Full Text] [Related]
7. Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study.
Valcárcel D; Sanz MA; Sureda A; Sala M; Muñoz L; Subirá M; Laborda R; Clopés A; Sierra J
Bone Marrow Transplant; 2002 May; 29(9):783-7. PubMed ID: 12040477
[TBL] [Abstract][Full Text] [Related]
8. Can 29kDa rhGM-CSF expressed by silkworm pupae bioreactor bring into effect as active cytokine through orally administration?
Zhang Y; Chen J; Lv Z; Nie Z; Zhang X; Wu X
Eur J Pharm Sci; 2006 Jun; 28(3):212-23. PubMed ID: 16616462
[TBL] [Abstract][Full Text] [Related]
9. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.
Mels AK; Statius Muller MG; van Leeuwen PA; von Blomberg BM; Scheper RJ; Cuesta MA; Beelen RH; Meijer S
Br J Surg; 2001 Apr; 88(4):539-44. PubMed ID: 11298622
[TBL] [Abstract][Full Text] [Related]
10. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
Akasheh M; Eastwood D; Vesole DH
Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
[TBL] [Abstract][Full Text] [Related]
11. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation for rhGM-CSF wound-healing efficacy in topical vehicles.
Memişoğlu E; Oner F; Ayhan A; Başaran I; Hincal AA
Pharm Dev Technol; 1997 May; 2(2):171-80. PubMed ID: 9552443
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of recombinant human granulocyte macrophage colony-stimulating factor in Macaca mulatta.
Wang RG; Zhu XZ; Song W
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):50-3. PubMed ID: 10375759
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies.
Richard C; Alsar MJ; Calavia J; Bello-Fernandez C; Baro J; Loyola I; Rios R; Cuadrado MA; Gonzalez-Pardo C; Iriondo A
Bone Marrow Transplant; 1993 Jun; 11(6):473-8. PubMed ID: 8334429
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds.
Yan H; Chen J; Peng X
Burns; 2012 Sep; 38(6):877-81. PubMed ID: 22652468
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
17. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant.
Vela-Ojeda J; Tripp-Villanueva F; Sanchez-Cortés E; Ayala-Sanchez M; García-Ruiz Esparza MA; Rosas-Cabral A; Gonzalez-Llaven J
Bone Marrow Transplant; 1999 Dec; 24(12):1307-10. PubMed ID: 10627639
[TBL] [Abstract][Full Text] [Related]
18. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.
Takahashi M; Aoki A; Mito M; Nikkuni K; Ohtsuka T; Saitoh H; Moriyama Y; Shibata A
Hematol Pathol; 1993; 7(3):153-8. PubMed ID: 8244908
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
